ClinicalTrials.gg
RecruitingNCT07467187HOMEVENT DKUpdated Apr 20, 2026

Invasive Home Ventilation in Denmark

An observational study in Neuromuscular Diseases (NMD), ALS (Amyotrophic Lateral Sclerosis) and Spinal Cord Injuries (SCI), sponsored by Rigshospitalet, Denmark. Recruiting at 1 site in Denmark. Per ClinicalTrials.gov, last updated 2026-04-20.

Sponsored by Rigshospitalet, Denmark · Observational

How we know

From the registry’s dates

  • Started Apr 2026; still recruiting 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
450
Sex
All
01

Study summary

The aim of this study is to describe national trends over the past 10 years in patients receiving invasive home mechanical ventilation (HMV) in Denmark. This includes indications for invasive HMV, diagnostic groups, and one-year mortality.

02

Conditions studied

  • Neuromuscular Diseases (NMD)
  • ALS (Amyotrophic Lateral Sclerosis)
  • Spinal Cord Injuries (SCI)
  • Duchenne Muscular Dystrophy (DMD)
  • SMA - Spinal Muscular Atrophy
  • MSA - Multiple System Atrophy
  • Tracheostomized Patients
  • Tracheostomy
03

In context

Neuromuscular Diseases

361 studies on the registry are indexed under Neuromuscular Diseases; 96 are open to participants now.

This study's planned enrollment of 450 is above the median of 72 across 144 observational studies indexed under Neuromuscular Diseases.

Browse Neuromuscular Diseases studies →

Lead sponsor

Rigshospitalet, Denmark is the lead sponsor of 1,004 studies on the registry; 173 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients in Denmark with a respiratory certified personale care assistent who are fully or partially dependent on invasive ventilation during the period 2016-2025.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients are included if they have or have had a respiratory certified personale care assistent during the period 2016-2025.

Exclusion criteria

Exclusion Criteria:

  • Not tracheostomized
  • Tracheostomized but on spontaneous breathing throughout 1 January 2016 - 31 December 2025
  • Not discharged to home, assisted living, nursing home, or rehabilitation during 1 January 2016 - 31 December 2025
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
450 participants (estimated)
Patient registry
No

Groups and cohorts

  • Invasive mechanical ventilation
06

What researchers measure

Primary outcomes

  1. Incidence of patients with invasive home mechanical ventilation

    Incidence of patients with invasive home mechanical ventilation per year per 100,000 population

    Time frame: Each year during the periode from 01.01.2016 to 12.31.2025

Secondary outcomes

  1. Prevalence of patients on home mechanical ventilation pr. year

    Time frame: Each year during the periode from 01.01.2016 to 12.31.2025

  2. Number of new patients on invasive home mechanical ventilation per year

    The absolute number of patients starting on invasive home mechanical ventilation each year.

    Time frame: Each year during the periode from 01.01.2016 to 12.31.2025

  3. One-year mortality

    1-year mortality after initiation of invasive home mechanical ventilation

    Time frame: Periode from 01.01.2016 to 12.31.2025

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2026 (actual). Primary completion is estimated for Sep 2028, 28 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 9, 2026
First posted
Mar 12, 2026
StartActual
Apr 13, 2026
Primary completionEst.
Sep 1, 2028
CompletionEst.
Sep 1, 2028
Last update
Apr 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07467187
Responsible party
Janne B Stokholm (Principal Investigator, Rigshospitalet, Denmark) — Principal investigator
First posted
Mar 12, 2026
Start date
Apr 13, 2026
Primary completion
Sep 1, 2028 (estimated)
Completion
Sep 1, 2028 (estimated)
Last update
Apr 20, 2026

Study contacts

Janne B Stokholm, M.D.
Contact
janne.boegh.stokholm.01@regionh.dk
+45 38632376
Anne-Katrine Staehr-Rye
Contact
anne.kathrine.staehr.rye@regionh.dk
+45 24455276

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion